
Panacea Biotec begins production of Sputnik V vaccine
The Hindu
India’s Panacea Biotec has started producing Sputnik V, the Russian COVID-19 vaccine.The first batch produced by the company’s facility in Baddi will be shipped to the Gamaleya Center in Russia for qu
India’s Panacea Biotec has started producing Sputnik V, the Russian COVID-19 vaccine. The first batch produced by the company’s facility in Baddi will be shipped to the Gamaleya Center in Russia for quality control. Full-scale production is due to start this summer, the Russian Direct Investment Fund (RDIF) and Panacea said in a joint statement on Monday. RDIF CEO Kirill Dmitriev said, “production of Sputnik V supports efforts of India’s authorities to leave behind the acute phase of coronavirus as soon as possible, while the vaccine will also be exported at a later stage to help prevent the spread of the virus in other countries around the world.”More Related News

Scaling Artificial Intelligence(AI) at the speed at which consultants project is not possible by the laws of physics and may not be environmentally sustainable, said Tanvir Khan, who is the Executive Vice President and Chief Operating Officer of NTT DATA North America, part of the Japanese technology services and data centre company NTT Data, in an interview with The Hindu.












